Monopar Therapeutics (MNPR) Assets (2016 - 2026)
Monopar Therapeutics (MNPR) recorded Assets of $134.98 million in Q2 2026, up 150.6% from $53.87 million a year earlier.
Powered by 
Analysis
Monopar Therapeutics (MNPR) Assets (2016 - 2026) Analysis & Trends
At the end of FY2025, Monopar Therapeutics reported Assets of $140.72 million, up 133.4% from FY2024.
- Annual Assets has a five-year compound annual growth rate of 52.8% (FY2020 to FY2025).
- Across earlier years, Assets came in at $60.29 million in FY2024 (+720.8%), $7.35 million in FY2023 (-44.5%), $13.23 million in FY2022 (-35.5%) and $20.52 million in FY2021 (+21.7%).
- Quarterly Assets has ranged from $6.07 million in Q3 2024 to $144.2 million in Q3 2025 over the past five years.
- On a year-over-year basis, Assets rose in five of the last six quarters, with growth averaging 357.3%.
- Peak year-over-year performance for Assets in the last five years was growth of 720.8% in Q4 2024, against a decline of 44.5% in Q4 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Monopar Therapeutics | 715.17 Mn | 433.40 Mn | - | 134.98 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 134.98 Mn |
| Dec 31, 2025 | 140.72 Mn |
| Sep 30, 2025 | 144.20 Mn |
| Jun 30, 2025 | 53.87 Mn |
| Mar 31, 2025 | 55.09 Mn |
| Dec 31, 2024 | 60.29 Mn |
| Sep 30, 2024 | 6.07 Mn |
| Jun 30, 2024 | 7.18 Mn |
| Mar 31, 2024 | 8.91 Mn |
| Dec 31, 2023 | 7.35 Mn |
| Sep 30, 2023 | 8.59 Mn |
| Jun 30, 2023 | 10.34 Mn |
| Mar 31, 2023 | 11.83 Mn |
| Dec 31, 2022 | 13.23 Mn |
| Sep 30, 2022 | 14.45 Mn |
| Jun 30, 2022 | 16.74 Mn |
| Mar 31, 2022 | 18.07 Mn |
| Dec 31, 2021 | 20.52 Mn |
| Sep 30, 2021 | 22.52 Mn |
| Jun 30, 2021 | 24.46 Mn |
API Access
Monopar Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=MNPR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "MNPR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=MNPR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();